Chorokbaem Healthcare Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 0.12%

Chorokbaem Healthcare Co Ltd (118000) has an Asset Resilience Ratio of 0.12% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩233.91 Million

≈ $158.52K USD Cash + Short-term Investments

Total Assets

₩188.61 Billion

≈ $127.82 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2013–2025)

This chart shows how Chorokbaem Healthcare Co Ltd's Asset Resilience Ratio has changed over time. Check asset allocation strategy of Chorokbaem Healthcare Co Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Chorokbaem Healthcare Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Chorokbaem Healthcare Co Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩233.91 Million	0.12%
Total Liquid Assets	₩233.91 Million	0.12%

Asset Resilience Insights

Limited Liquidity: Chorokbaem Healthcare Co Ltd maintains only 0.12% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Chorokbaem Healthcare Co Ltd Industry Peers by Asset Resilience Ratio

Compare Chorokbaem Healthcare Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
AstraZeneca PLC LSE:AZN	Drug Manufacturers - General	0.10%
AbbVie Inc NYSE:ABBV	Drug Manufacturers - General	0.02%
AstraZeneca PLC MX:AZNN	Drug Manufacturers - General	0.03%
Novartis AG SW:NOVN	Drug Manufacturers - General	0.08%
Virbac SA PA:VIRP	Drug Manufacturers - General	0.23%
Zhejiang Int'L Group Co Ltd SHE:000411	Drug Manufacturers - General	0.00%
Firebrick Pharma Ltd AU:FRE	Drug Manufacturers - General	0.29%
Eli Lilly and Company SA:LILY34	Drug Manufacturers - General	8.63%

Annual Asset Resilience Ratio for Chorokbaem Healthcare Co Ltd (2013–2025)

The table below shows the annual Asset Resilience Ratio data for Chorokbaem Healthcare Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.11%	₩225.32 Million ≈ $152.70K	₩197.96 Billion ≈ $134.16 Million	+0.08pp
2024-12-31	0.03%	₩55.00 Million ≈ $37.27K	₩157.82 Billion ≈ $106.95 Million	-1.46pp
2023-12-31	1.49%	₩2.32 Billion ≈ $1.57 Million	₩155.30 Billion ≈ $105.25 Million	+0.83pp
2022-12-31	0.67%	₩1.27 Billion ≈ $858.83K	₩189.86 Billion ≈ $128.66 Million	+0.10pp
2020-12-31	0.57%	₩787.10 Million ≈ $533.41K	₩138.29 Billion ≈ $93.72 Million	-17.34pp
2019-12-31	17.91%	₩12.50 Billion ≈ $8.47 Million	₩69.80 Billion ≈ $47.31 Million	+16.05pp
2018-12-31	1.86%	₩1.14 Billion ≈ $773.15K	₩61.44 Billion ≈ $41.64 Million	-0.49pp
2017-12-31	2.35%	₩863.06 Million ≈ $584.89K	₩36.74 Billion ≈ $24.90 Million	-35.20pp
2016-12-31	37.55%	₩10.83 Billion ≈ $7.34 Million	₩28.84 Billion ≈ $19.55 Million	+36.97pp
2015-12-31	0.58%	₩94.51 Million ≈ $64.05K	₩16.41 Billion ≈ $11.12 Million	-4.36pp
2014-12-31	4.94%	₩972.03 Million ≈ $658.73K	₩19.67 Billion ≈ $13.33 Million	-3.14pp
2013-12-31	8.08%	₩1.77 Billion ≈ $1.20 Million	₩21.97 Billion ≈ $14.89 Million	--

pp = percentage points

About Chorokbaem Healthcare Co Ltd

KO:118000 Korea Drug Manufacturers - General

Market Cap

$16.37 Million

₩24.15 Billion KRW

Market Cap Rank

#25749 Global

#1916 in Korea

Share Price

₩1406.00

Change (1 day)

+4.69%

52-Week Range

₩222.00 - ₩2080.00

All Time High

₩13800.00